Several benzoquinone ansamycins, such as geldanamycin and herbimycin A, have received much attention because of the multifaceted assault it provides against cancer by inhibiting apoptosis, oncogenesis, cell cycle progression, and cell proliferation by inhibiting Hsp90 functions [157]. The gene discussed is HSP90AA1; the disease is cancer.